REGI U.S., INC.
An Oregon State Corporation
Financial Statements (Unaudited)
April 30, 2022 and 2021
REGI U.S., INC.
Years Ended April 30, 2022 and 2021
Table of Contents
Financial Statements (Unaudited) | |
Consolidated Balance Sheets .......................................................................................................................... | 1 |
Consolidated Statements of Operations and Comprehensive Loss ................................................................ | 3 |
Consolidated Statements of Changes Stockholders' Equity............................................................................ | 4 |
Consolidated Statements of Cash Flows ......................................................................................................... | 5 |
Notes to the Consolidated Financial Statements ........................................................................................... | 6 |
REGI U.S., INC.
CONSOLIDATED BALANCE SHEETS
April 30, 2022 and 2021 (unaudited)
Assets | |||||
Current assets | 2022 | 2021 | |||
$ | 26,846 | ||||
Cash and cash equivalents | $ | 20,030 | |||
Inventory | 2,000 | 2,000 | |||
Prepaid expense | 15,347 | 31,821 | |||
Deposit | 7,500 | 7,500 | |||
Total current assets | 51,693 | 61,351 | |||
Property and equipment, net | 4,221 | 96,387 | |||
Total assets | $ | 55,914 | $ | 157,738 | |
Liabilities and Stockholders' Equity (Deficit) | |||||
Current liabilities | 2022 | 2021 | |||
$ | 36,842 | ||||
Accounts payable | $ | 40,569 | |||
Accounts payable ‐ related party | 32,651 | 54,722 | |||
Accrued expenses | 1,789,462 | 1,367,672 | |||
Accrued interest | 456,077 | 198,117 | |||
Accrued interest ‐ related party | 315,015 | 210,983 | |||
Due to related parties | 138,303 | 139,251 | |||
Convertible promissory notes ‐ current portion, net of unamortized | 936,313 | 915,956 | |||
discount of $0 and $9,691 respectively | |||||
Convertible promissory notes ‐ current portion, net of unamortized | 811,741 | 821,238 | |||
discount of $0 and $1,232 respectively ‐ related party | |||||
Current portion of notes payable | 7,042 | 22,015 | |||
Current portion of notes payable ‐ related party | 250,000 | 250,000 | |||
Total current liabilities | 4,773,446 | 4,020,523 | |||
Long term liabilities | |||||
RadWater R&D funding advance | 135,015 | 135,015 | |||
Notes payable, net of current portion | 8,441 | 65,885 | |||
Total long term liabilities | 143,456 | 200,900 | |||
Total liabilities | 4,916,902 | 4,221,423 | |||
Commitments and contingencies | ‐ | ‐ |
See accompanying notes to the financial statements.
‐1‐
REGI U.S., INC.
CONSOLIDATED BALANCE SHEETS (CONT'd)
April 30, 2022 and 2021 (unaudited)
Stockholders' equity (deficit) | |||||
Capital, Unlimited shares authorized, no par value, 122,533,953 and | 25,611,884 | ||||
121,767,953 shares issued and outstanding respectively | 25,400,911 | ||||
Accumulated other comprehensive income | (367,494) | (362,775) | |||
Accumulated deficit | (30,160,161) | (29,156,604) | |||
Total REGI US, Inc. stockholders' equity (deficit) | (4,915,771) | (4,118,468) | |||
Non‐controlling interest | 54,783 | 54,783 | |||
Total stockholders' equity (deficit) | (4,860,988) | (4,063,685) | |||
Total liabilities and stockholders' equity (deficit) | $ | 55,914 | $ | 157,738 |
See accompanying notes to the financial statements.
‐2‐
REGI U.S., INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Years Ended April 30, 2022 and 2021 (unaudited)
2022 | 2021 | |||||
Revenue | $ | 83,700 | $ | 60,330 | ||
Operating expenses | 49,135 | |||||
Accounting and legal | 22,877 | |||||
Compensation and consulting | 614,025 | 535,753 | ||||
Stockholder relations | 17,364 | 16,570 | ||||
Depreciation and amortization | 7,875 | 34,213 | ||||
General and administrative expenses | 70,921 | 75,863 | ||||
Research and development | 11,180 | 111,735 | ||||
Total operating expenses | 770,500 | 797,011 | ||||
Loss from operations | (688,212) | (740,825) | ||||
Other income (expenses) | (346,941) | |||||
Interest and financing expense | (102,754) | |||||
Interest expense, related party | (26,669) | (117,878) | ||||
Amortization of derivative and debt discount | (10,922) | (84,466) | ||||
Gain (loss) on sale of lab equipment | 30,053 | ‐ | ||||
Grant income | 34,957 | ‐ | ||||
SBA PPP loan forgiveness | ‐ | 42,189 | ||||
Miscellaneous income | 4,177 | ‐ | ||||
Gain on settlement of liability | ‐ | 683 | ||||
Total other income (expense) | (315,345) | (262,226) | ||||
Net loss before non‐controlling interest | (1,003,557) | (1,003,051) | ||||
Net loss attributable to non‐controlling interest | ‐ | ‐ | ||||
Net loss attributed to the Company | $ | (1,003,557) | $ | (1,003,051) | ||
Loss per share ‐ basic and diluted | $ | (0.00) | $ | (0.01) | ||
Weighted average number of common shares outstanding ‐ basic and | 121,895,969 | 121,747,832 | ||||
diluted | ||||||
Comprehensive loss: | $ | (1,003,557) | ||||
Net loss | $ | (1,003,051) | ||||
Translation adjustments | (4,719) | ‐ | ||||
Comprehensive loss | (1,008,276) | (1,003,051) | ||||
Comprehensive loss attributable to non‐controlling interest | ‐ | ‐ | ||||
Comprehensive loss attributable to REGI U.S., Inc. | $ | (1,008,276) | $ | (1,003,051) |
See accompanying notes to the financial statements.
‐3‐
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
REGI U.S. Inc. published this content on 22 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 July 2022 16:43:07 UTC.